REAL-WORLD TREATMENT INTERVALS WITH BOTULINUM NEUROTOXIN TYPE A IN POSTSTROKE SPASTICITY MANAGEMENT-ARE DIFFERENT FORMULATIONS DIFFERENT?

被引:0
|
作者
Rosa, Susana [1 ]
Guimaraes, Bruno [2 ]
Martins, Joana [3 ]
Mesquita, Jose Luis [4 ]
Freitas, Margarida [5 ]
Jacinto, Jorge [6 ]
机构
[1] Ctr Hosp Univ Lisboa Cent CHULC, Dept Phys & Rehabil Med, P-1069166 Lisbon, Portugal
[2] Ctr Hosp Entre Douro eVouga CHEDV, Dept Phys & Rehabil Med, Santa Maria Feira, Portugal
[3] Ctr Hosp Univ Coimbra CHUC, Dept Phys & Rehabil Med, Coimbra, Portugal
[4] Ctr Hosp Univ Lisboa Norte CHULN, Dept Phys & Rehabil Med, Lisbon, Portugal
[5] Hosp Garcia de Orta, Dept Phys & Rehabil Med, Almada, Portugal
[6] Ctr Med Reabilitacao Alcoitao, Dept Phys & Rehabil Med, Serv Reabilitacao Adultos, Estoril, Portugal
关键词
Botulinum neurotoxin type A; Injections; Poststroke spasticity; Time intervals;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S63 / S63
页数:1
相关论文
共 50 条
  • [21] Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study
    Norgaard, Kirsten
    Ranjan, Ajenthen G.
    Laugesen, Christian
    Tidemand, Katrine G.
    Green, Allan
    Selmer, Christian
    Svensson, Jannet
    Andersen, Henrik U.
    Vistisen, Dorte
    Carstensen, Bendix
    DIABETES CARE, 2023, 46 (11) : 1958 - 1964
  • [22] Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups
    Hauser, Barbara
    Alonso, Nerea
    Riches, Philip L.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [23] A multicenter, double-blind, randomized, placebo-controlled, parallel study of the safety and efficacy of BOTOX (botulinum toxin type A) purified neurotoxin in the treatment of focal upper limb spasticity poststroke
    Brashear, A
    Gordon, MF
    Elovic, E
    Kassicieh, D
    Marciniak, C
    Turkel, C
    Do, M
    Jenkins, SW
    NEUROLOGY, 2001, 56 (08) : A78 - A78
  • [24] A real-world study of glucocorticoid treatment in COVID-19 patients with different disease severities
    Jiao, Xiaofei
    Wang, Ya
    Liu, Dan
    Zeng, Shaoqing
    Chi, Jianhua
    Li, Ruyuan
    Yu, Yang
    Yu, Ruidi
    Wang, Siyuan
    Yuan, Yuan
    Gao, Yue
    Xu, Sen
    Li, Chunrui
    Gao, Qinglei
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (08):
  • [25] Real-world safety and effectiveness of ocrelizumab in different treatment lines in RMS - CONFIDENCE interim analysis
    Buttmann, M.
    Weber, M.
    Meuth, S.
    Dirks, P.
    Eggebrecht, J.
    Bluemich, S.
    Hieke-Schulz, S.
    Leemhuis, J.
    Ziemssen, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 181 - 181
  • [26] Different dosing strategies of pembrolizumab in the treatment of NSCLC: A real-world retrospective observational study.
    Janzic, Urska
    Rus, Zala
    Knez, Lea
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Comparison of the real-world costs associated with different treatment patterns in adults initiating apremilast or biologics for the treatment of psoriasis
    Feldman, Steven
    Bonafede, Machaon
    Pelletier, Corey
    Mehta, Rina
    Wilson, Kathleen
    Smith, David
    Brouillette, Matthew
    Li, Qing
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB84 - AB84
  • [28] Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study
    Sbraccia, Paolo
    Aberle, Jens
    Olsen, Anne Helene
    Rathor, Naveen
    Major-Pedersen, Atheline
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 985 - 991
  • [29] Glucometrics and device satisfaction in children and adolescents with type 1 diabetes using different treatment modalities: A multicenter real-world observational study
    Cherubini, Valentino
    Fargalli, Andrea
    Arnaldi, Claudia
    Bassi, Marta
    Bonfanti, Riccardo
    Bracciolini, Giulia Patrizia
    Cardella, Francesca
    Dal Bo, Sara
    Delvecchio, Maurizio
    Di Candia, Francesca
    Franceschi, Roberto
    Galassi, Sabrina Maria
    Gallo, Francesco
    Graziani, Vanna
    Iannilli, Antonio
    Mameli, Chiara
    Marigliano, Marco
    Minuto, Nicola
    Monti, Sara
    Mozzillo, Enza
    Pascarella, Filomena
    Predieri, Barbara
    Rabbone, Ivana
    Roppolo, Rosalia
    Schiaffini, Riccardo
    Tiberi, Valentina
    Tinti, Davide
    Toni, Sonia
    Scaramuzza, Andrea
    Vestrucci, Benedetta
    Gesuita, Rosaria
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 210
  • [30] Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study
    Di Molfetta, S.
    Rossi, A.
    Gesuita, R.
    Faragalli, A.
    Cutruzzola, A.
    Irace, C.
    Minuto, N.
    Pitocco, D.
    Cardella, F.
    Arnaldi, C.
    Frongia, A.
    Mozzillo, E.
    Predieri, B.
    Fiorina, P.
    Giorgino, F.
    Cherubini, V.
    ACTA DIABETOLOGICA, 2024,